Sagespring Wealth Partners’s Boston Scientific BSX Stock Holding History

Sagespring Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$811K	Sell	12,918 -606	-4%	-$48.5K	0.01%	377
2025 Q4	$1.29M	Sell	13,524 -2,277	-14%	-$223K	0.02%	260
2025 Q3	$1.54M	Buy	15,801 +2,965	+23%	+$307K	0.03%	224
2025 Q2	$1.38M	Buy	12,836 +1,230	+11%	+$124K	0.03%	223
2025 Q1	$1.17M	Buy	11,606 +1,431	+14%	+$144K	0.03%	221
2024 Q4	$909K	Buy	+10,175	New	+$896K	0.02%	237

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sagespring Wealth Partners's BSX Position: Q1 2026 in Review

Sagespring Wealth Partners reduced its Boston Scientific (BSX) stake by 4.5% in Q1 2026, selling an estimated $48.5K and leaving 12,918 shares worth $811K. The position accounts for 0.01% of the portfolio, ranked #377.

Sagespring Wealth Partners first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.54M in Q3 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Sagespring Wealth Partners held 12,918 shares of Boston Scientific worth $811K as of Q1 2026.
Sagespring Wealth Partners sold 606 Boston Scientific shares in Q1 2026, an estimated $48.5K.
Boston Scientific made up 0.01% of Sagespring Wealth Partners's portfolio in Q1 2026, its #377 holding.
Sagespring Wealth Partners first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
Sagespring Wealth Partners's Boston Scientific position peaked at $1.54M in Q3 2025.
1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Sagespring Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.